The funding from the Development Bank of Wales will allow the adventure hub to replace diesel power with solar energy.
"As an outdoor business in one of Wales' most impressive natural environments, our environmental impact is at the forefront of everything we do and we want to take every step we can to minimise our energy consumption and our carbon footprint. We know that this is something that's also really important to our customers, who love the environment we have here and want to work with businesses and attractions who are working hard to preserve it."
The premium ticketing platform has raised £14.5m in an extended Series A round led by Nickleby Capital.
"The experience economy is rapidly becoming the backbone of the music industry, as fans increasingly seek out not just live performances, but unforgettable, one-of-a-kind experiences. Given the significance of these occasions, fans want to be certain that they are buying from a trusted and transparent company that only uses genuine sources. We are delighted with the recent growth that Seat Unique has seen, and the knowledge, connections and resources that these new investors bring will help us take advantage of the huge opportunities ahead of us"
The round was led by BGF, Shell Ventures, and Move Energy alongside existing investors Barclays and Clean Growth Fund.
"We are thrilled to have BGF and Shell Ventures support in our mission to decarbonise cold chain logistics. Their investment, alongside the continued backing of our existing investors, is a real validation of Sunswap’s journey to date. This funding will be instrumental in accelerating our growth and expanding our presence in the UK and European markets. It will enable us to ramp up production, support further customer trials, and invest in the development of our zero-emission technology. Together, we will work towards a cleaner, greener future for cold chain logistics, helping businesses meet their sustainability targets."
The university spin-out has raised over £1m in total funding to develop targeted cancer therapeutics.
"Our technology opens up a new space in oncology drug discovery, to treat a range of malignancies, including rare cancers that currently have no effective treatment options. We are confident that the combined backing of the Development Bank and Start Codon, alongside the universities and M-Sparc, means that we now have the support to fast-track our innovative science into a successful global commercial venture that could help treat cancers."
